Literature DB >> 22235932

Anti-tumour and immunomodulating activities of diosgenin, a naturally occurring steroidal saponin.

Zhongmei He1, Yudan Tian, Xiantao Zhang, Bai Bing, Lianxue Zhang, Huaisheng Wang, Wenjie Zhao.   

Abstract

Diosgenin is a naturally occurring steroidal saponin abundantly present in many medical plants. In this study, diosgenin could significantly inhibit the growth of sarcoma-180 tumour cells in vivo, and remarkably increase thymus and spleen weights of S-180-bearing mice and upgrade the secretion level of TNF-α in serum. Moreover, diosgenin could stimulate lymphocyte transformation and enhance phagocytic capability of macrophages in vitro, and remarkably promoted the secretion of NO and TNF-α in macrophages. These results suggested that diosgenin could improve both specific and non-specific cellular immune responses, and the anti-tumour effects of diosgenin were achieved by immunostimulating properties instead of direct cytotoxicity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22235932     DOI: 10.1080/14786419.2011.648192

Source DB:  PubMed          Journal:  Nat Prod Res        ISSN: 1478-6419            Impact factor:   2.861


  11 in total

1.  Role of SB203580 in the regulation of human esophageal cancer cells under the effection of Diosgenin.

Authors:  Weiliang Ding; Yancai Jiang; Yaping Jiang; Taofeng Zhu; Ying Xu; Wenjie Jiang; Wenjiao Zhu; Zhian Tang; Zhijun Ge; Tieliang Ma; Yongfei Tan
Journal:  Int J Clin Exp Med       Date:  2015-02-15

2.  Anti-inflammatory activity of liposomes of Asparagus racemosus root extracts prepared by various methods.

Authors:  Nathsiree Plangsombat; Kanin Rungsardthong; Lalana Kongkaneramit; Neti Waranuch; Narong Sarisuta
Journal:  Exp Ther Med       Date:  2016-09-05       Impact factor: 2.447

3.  Synthesis and Antitumor Activity of Diosgenin Hydroxamic Acid and Quaternary Phosphonium Salt Derivatives.

Authors:  Lin Wang; Maoling Yao; Yuegao Hu; Congdi Chen; Liming Jin; Xiaodong Ma; Hongjun Yang
Journal:  ACS Med Chem Lett       Date:  2022-04-19       Impact factor: 4.632

4.  Diosgenin relieves goiter via the inhibition of thyrocyte proliferation in a mouse model of Graves' disease.

Authors:  Hu Cai; Zhe Wang; Hai-qing Zhang; Fu-rong Wang; Chun-xiao Yu; Feng-xia Zhang; Ling Gao; Jian Zhang; Jia-jun Zhao
Journal:  Acta Pharmacol Sin       Date:  2013-11-18       Impact factor: 6.150

Review 5.  Hybrid Drugs-A Strategy for Overcoming Anticancer Drug Resistance?

Authors:  Marta Szumilak; Anna Wiktorowska-Owczarek; Andrzej Stanczak
Journal:  Molecules       Date:  2021-04-29       Impact factor: 4.411

Review 6.  New Therapeutic Horizon of Graves' Hyperthyroidism: Treatment Regimens Based on Immunology and Ingredients From Traditional Chinese Medicine.

Authors:  Qiongyao He; Hui Dong; Minmin Gong; Yujin Guo; Qingsong Xia; Jing Gong; Fuer Lu
Journal:  Front Pharmacol       Date:  2022-04-05       Impact factor: 5.988

7.  Anti- trachea inflammatory effects of diosgenin from Dioscorea nipponica through interactions with glucocorticoid receptor α.

Authors:  Yang Junchao; Wang Zhen; Wang Yuan; Xu Liying; Jiang Libin; Zhu Yuanhong; Zhao Wei; Chen Ruilin; Zhai Lu
Journal:  J Int Med Res       Date:  2016-12-07       Impact factor: 1.671

Review 8.  The Dioscorea Genus (Yam)-An Appraisal of Nutritional and Therapeutic Potentials.

Authors:  Jude E Obidiegwu; Jessica B Lyons; Cynthia A Chilaka
Journal:  Foods       Date:  2020-09-16

9.  Optimization of diosgenin extraction from Dioscorea deltoidea tubers using response surface methodology and artificial neural network modelling.

Authors:  Romaan Nazir; Devendra Kumar Pandey; Babita Pandey; Vijay Kumar; Padmanabh Dwivedi; Aditya Khampariya; Abhijit Dey; Tabarak Malik
Journal:  PLoS One       Date:  2021-07-21       Impact factor: 3.240

10.  Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota.

Authors:  Mengxue Dong; Zhefeng Meng; Kudelaidi Kuerban; Feilong Qi; Jiayang Liu; Yuxi Wei; Qian Wang; Shanshan Jiang; Meiqing Feng; Li Ye
Journal:  Cell Death Dis       Date:  2018-10-10       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.